Fluvoxamine suppresses the long-term potentiation in the hippocampal CA1 field of anesthetized rats: An effect mediated via 5-HT1A receptors

Brain Research

Volumn 959, Issue 1, 2003, Pages 165-168

  Kojima, Taku ^a   Matsumoto, Machiko ^a   Togashi, Hiroko ^a   Tachibana, Kaori ^a   Kemmotsu, Osamu ^a   Yoshioka, Mitsuhiro ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

5 HT1A receptor; Fluvoxamine; Hippocampal CA1 field; Long term potentiation; Synaptic plasticity

Indexed keywords

1 (2 METHOXYPHENYL) 4 (4 PHTHALIMIDOBUTYL)PIPERAZINE; 1 METHYL 3 INDOLECARBOXYLIC ACID [1 [2 (METHYLSULFONYLAMINO)ETHYL] 4 PIPERIDINYLMETHYL] ESTER; DR 4004; FLUVOXAMINE; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN 4 ANTAGONIST; SEROTONIN 7 RECEPTOR; SEROTONIN ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG MECHANISM; HIPPOCAMPUS; LONG TERM POTENTIATION; MALE; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPTIC TRANSMISSION;

ANIMALS; EVOKED POTENTIALS; FLUVOXAMINE; HIPPOCAMPUS; LONG-TERM POTENTIATION; MALE; NEURONAL PLASTICITY; PIPERAZINES; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS;

EID: 0037414702     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)03756-3     Document Type: Article

References (23)

1. Bliss T.V., Goddard G.V., Riives M. Reduction of long-term potentiation in the dentate gyrus of the rat following selective depletion of monoamines. J. Physiol (Lond). 334:1983;475-491.
2. Bliss T.V., Collingridge G.L. A synaptic model of memory:Long-term potentiation in the hippocampus. Nature. 361:1993;31-39.
3. Figgitt D.P., McClellan K.J. Fluvoxamine. An updated review of its use in the management of adults with anxiety disorders. Drugs. 60:2000;925-954.
4. Foy M.R., Stanton M.E., Levine S., Thompson R.F. Behavioural stress impairs long-term potentiation in rodent hippocampus. Behav. Neural Biol. 48:1987;138-149.
5. 1A receptor antagonists NAN-190 and BMY 7378 are partial agonists in the rat dorsal raphe nucleus in vitro. Eur. J. Pharmacol. 211:1992;211-219.
6. Iga Y., Arisawa H., Ise M., Yasuda H., Takeshita Y. Modulation of rhythmical slow activity, long-term potentiation and memory by muscarinic receptor agonists. Eur. J. Pharmacol. 308:1996;13-19.
7. Kehoe P., Hoffman J.H., Austin-LaFrance R.J., Bronzino J.D. Neonatal isolation enhances hippocampal dentate response to tetanization in freely moving juvenile male rats. Exp. Neurol. 136:1995;89-97.
8. 7 receptor. J. Med. Chem. 42:1999;533-535.
9. Kim J.J., Fanselow M.S. Modality-specific retrograde amnesia of fear. Science. 256:1992;675-677.
10. Li X.B., Inoue T., Hashimoto S., Koyama T. Effect of chronic administration of flesinoxan and fluvoxamine on freezing behavior induced by conditioned fear. Eur. J. Pharmacol. 425:2001;43-50.
11. Maki Y., Inoue T., Izumi T., Muraki I., Ito K., Kitaichi Y., Li X., Koyama T. Monoamine oxidase inhibitors reduce conditioned fear stress-induced freezing behavior in rats. Eur. J. Pharmacol. 406:2000;411-418.
12. Markstein R., Matsumoto M., Kohler C., Togashi H., Yoshioka M., Hoyer D. Pharmacological characterization of 5-HT receptors positively coupled to adenylyl cyclase in the rat hippocampus. Naunyn-Schmiedeberg's Arch. Pharmacol. 359:1999;454-459.
13. 4 receptors in cholinergic function associated with cognitive processes: behavioral, electrophysiological, and neurochemical studies. J. Pharmacol. Exp. Ther. 29:2001;676-682.
14. M. Matsumoto, T. Kojima, H. Togashi, K. Mori, S. Ohashi, K. Ueno, M. Yoshioka, Differential characteristics of endogenous serotonin-mediated synaptic transmission in the hippocampal CA1 and CA3 fields of anesthetized rats, Naunyn-Shcmiderberg's Arch. Pharmacol. (2002) in press.
15. Miyamoto J., Tsuji M., Takeda J., Nawa H., Matsumiya T. Pretreatment with diazepam suppresses the reduction in defensive freezing behavior induced by fluvoxamine in the conditioned fear stress paradigm in mice. Eur. J. Pharmacol. 409:2000;81-84.
16. 1A agonist tandospirone, on hippocampal long-term potentiation in vivo. Pharmacol. Biochem. Behav. 69:2001;367-372.
17. 1A receptor antagonist WAY 100635 on the inhibition of e.p.s.ps produced by 5-HT in the CA1 region of rat hippocampal slices. Br. J. Pharmacol. 124:1998;93-100.
18. Schreiber R., Melon C., De Vry J. The role of 5-HT receptor subtypes in the anxiolytic effects of selective serotonin reuptake inhibitors in the rat ultrasonic vocalization test. Psychopharmacology. 135:1998;383-391.
19. Shakesby A.C., Anwyl R., Rowan M.J. Overcoming the effects of stress on synaptic plasticity in the intact hippocampus: rapid actions of serotonergic and antidepressant agents. J. Neurosci. 22:2002;3638-3644.
20. Sheehan D.V., Raj B.A., Trehan R.R., Knapp E.L. Serotonin in panic disorder and social phobia. Int. Clin. Psychopharmacol. Suppl. 2:1993;63-77.
21. Shors T.J., Seib T.B., Levine S., Thompson R.F. Inescapable versus escapable shock modulates long-term potentiation in the rat hippocampus. Science. 244:1989;224-226.
22. 1A agonists suppress firing activity of dorsal hippocampus CA1 pyramidal neurons through a postsynaptic mechanism: single-unit study in unanesthetized, unrestrained rats. J. Pharmacol. Exp. Ther. 288:1999;843-848.
23. Von Frijtag J.C., Kamal A., Reijmers L.G., Schrama L.H., van den Bos R., Spruijt B.M. Chronic imipramine treatment partially reverses the long-term changes of hippocampal synaptic plasticity in socially stressed rats. Neurosci. Lett. 309:2001;153-156.